Conformational Effects of Clinically Approved BTK Inhibitors and Mechanisms of BTK Resistance Mutations in Chronic Lymphocytic Leukemia
This research paper investigates the distinct conformational changes induced by clinically approved BTK inhibitors on full-length BTK and elucidates the mechanisms of action of BTK resistance mutations, particularly T474I and L528W, in chronic lymphocytic leukemia.